藥物供給管理(PBM)的美國市場 - 市場規模，佔有率，趨勢分析:不同商業模式，各最終用途，市場區隔預測(2023年～2030年)

美國的藥物供給管理(PBM)的市場規模在2030年前將達到9,340億美元，在2023年到2030年間預計將以8.77％的速度成長。

主要醫療費的增加，藥物供給管理(PBM)的偏好的提升，對處方藥的需求的增加，促進了市場成長。

本報告提供美國的藥物供給管理(PBM)市場相關調查分析，提供市場趨勢，市場區隔分析，地區分析，競爭情形等資訊。

目錄

第1章 調查範圍和目的

第2章 調查手法

第3章 摘要整理

• 市場預測
• 市場區隔預測
  • 經營模式
  • 最終用途
    • 競爭的考察

第4章 市場變數，趨勢，範圍

• 市場系列預測
  • 母企業的市場預測
  • 附隨物/關聯的市場預測
• 市場動態
  • 推動市場要素的分析
  • 阻礙市場要素的分析
• 滲透與成長預測的製圖
• 商業環境分析工具
  • 波特的五力分析
  • PESTEL分析
• COVID-19影響:質性分析

第5章 美國的藥物供給管理(PBM)市場:經營模式分析

• 美國的藥物供給管理(PBM)的經營模式的市場佔有率分析(2022年·2030年)
• 美國的藥物供給管理(PBM)的經營模式市場:市場區隔儀表板
• 經營模式市場區隔的市場規模與預測，趨勢的分析(2017年～2030年)
  • 獨立的PBM
  • 健康保險企業
  • 零售藥局

第6章 美國的藥物供給管理(PBM)市場:最終用途分析

• 美國的藥物供給管理(PBM)的最終用途的市場佔有率分析(2022年·2030年)
• 美國的藥物供給管理(PBM)的最終用途市場:市場區隔儀表板
• 最終用途市場區隔的市場規模與預測，趨勢的分析(2017年～2030年)
  • 商業
  • 聯邦政府

第7章 競爭分析

• 最近的趨勢及影響分析:各主要打入市場企業
• 競爭的分類(主要創新者，市場領導者，新興企業)
• 企業的市場地位的分析
• 企業簡介
  • CVS HEALTH
  • Elixir Rx Solutions LLC
  • Optum, Inc
  • Cigna
  • Change Healthcare
  • MedImpact
  • Prime Therapeutics LLC
  • HUB International Limited.
  • Anthem

U.S. Pharmacy Benefit Management Market Growth & Trends:

The U.S. pharmacy benefit management market size is expected to reach USD 934.0 billion by 2030, exhibiting a CAGR of 8.77% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increase in healthcare cost, the growing preference for pharmacy benefit management (PBM), and increased demand for prescription drugs are primarily driving the market growth.

PBMs operate with specialty pharmacies to enable beneficiaries to better adherence. These systems provide wide expertise and connections with pharmaceutical companies that can be beneficial to establish drug contracts. Payers find it difficult to establish value-based contracts with pharmaceutical companies. Therefore, payers promote themselves as negotiators and tend to receive considerable discounts on prescription drugs

The vertical integration of pharmacy benefit management (PBM) organizations with health insurance companies is poised to result in increased control of PBMs over distribution systems. This is likely to cause a rise in rebates, ultimately increasing the cost of drug list prices. Moreover, it will result in a monopoly of a certain market player, concentrating sales and revenue generation.

The business of insuring and administering employee benefit programs in the country, especially, health care programs, is heavily regulated by federal and state laws and administrative agencies, such as the Department of Health and Human Services (HHS), State Departments of Insurance, Centers for Medicare & Medicaid Services (CMS), Internal Revenue Services, and Departments of Labor.

The U.S. market for PBM is further fueled by the increasing number of mergers and collaborations between pharmacy benefit management businesses and health insurance providers for bettering the affordability and customization of health insurance policies. Additionally, the launch of enhanced benefit management services, such as disease management, drug utilization programmes, and pharmacy-medical integrated goods, is expected to bode well for the market.

U.S. Pharmacy Benefit Management Market Report Highlights:

• The standalone segment accounted for the largest revenue share in 2022 owing to the high number of claims processing by PBM. The health insurance segment is expected to witness a significant growth rate during the forecast period

• Based on end-use, the commercial segment accounted for the largest market share in 2022. The growth of the segment is attributed due to the proliferated usage of private insurance by the public and the increased cost of drugs

• In February 2022, Southern Scripts, one of the top PBM launched RxCompass, a new solution for mitigating the high cost of prescription drugs for companies and employees in the U.S.

• In July 2021, major insurers Humana and Anthem announced a partnership with SS&C, a software solutions provider to create a new PBM company named DomaniRx

Table of Contents

Chapter 1 Report Scope and Objectives

• 1.1 Market Segmentation
• 1.2 Regional Scope
• 1.3 Estimates and Forecast Timeline
• 1.4 Research Objectives
  • 1.4.1 Objective - 1
  • 1.4.2 Objective - 2
  • 1.4.3 Objective - 3

Chapter 2 Methodology

• 2.1 Research Methodology
• 2.2 Information Procurement
  • 2.2.1 Purchased Database
  • 2.2.2 GVR's Internal Database
  • 2.2.3 Secondary Sources
  • 2.2.4 Primary Research
  • 2.2.5 Details of Primary Research
• 2.3 Information or Data Analysis
  • 2.3.1 Data Analysis Models
• 2.4 Market Formulation & Validation
• 2.5 Model Details
  • 2.5.1 Commodity Flow Analysis
• 2.6 List of Secondary Sources
• 2.7 List of Abbreviations

Chapter 3 Executive Summary

• 3.1 Market Outlook
• 3.2 Segment Outlook
  • 3.2.1 Business Model
  • 3.2.2 End - use
    • 3.3Competitive Insights

Chapter 4 Market Variables, Trends & Scope

• 4.1 Market Lineage outlook
  • 4.1.1 Parent market outlook
  • 4.1.2 Ancillary/related market outlook
• 4.2 Market Dynamics
  • 4.2.1 Market driver analysis
    • 4.2.1.1 Vertical integration of key market players
    • 4.2.1.2 Introduction of improved health benefit plans
    • 4.2.1.3 Growing prevalence of chronic diseases in the U.S.
  • 4.2.2 Market restraint analysis
    • 4.2.2.1 Stringent regulations to cut back rebates
• 4.3 Penetration & Growth Prospect Mapping
• 4.4 Business Environment Analysis Tools
  • 4.4.1 Porter's Five Forces analysis
    • 4.4.1.1 Competitive rivalry
    • 4.4.1.2 Threat of new entrants
    • 4.4.1.3 Bargaining power of buyers
    • 4.4.1.4 Bargaining power of suppliers
    • 4.4.1.5 Threat of substitutes
  • 4.4.2 PESTEL Analysis
    • 4.4.2.1 Political landscape
    • 4.4.2.2 Economic and social landscape
    • 4.4.2.3 Technological landscape
• 4.3 Impact of COVID - 19: Qualitative Analysis

Chapter 5 U.S. Pharmacy Benefit Management Market: Business Model Analysis

• 5.1 U.S. Pharmacy Benefit Management Business Model Market Share Analysis, 2022 & 2030
• 5.2 U.S. Pharmacy Benefit Management Business Model Market: Segment Dashboard
• 5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Business Model Segment
  • 5.3.1 Standalone PBM
    • 5.3.1.1 Standalone PBM market, 2017 - 2030 (USD Billion)
  • 5.3.2 Health Insurance Providers
    • 5.3.2.1 Health insurance providers market, 2017 - 2030 (USD Billion)
  • 5.3.3 Retail Pharmacy
    • 5.3.3.1 Retail pharmacy market, 2017 - 2030 (USD Billion)

Chapter 6 U.S. Pharmacy Benefit Management Market: End - use Analysis

• 6.1 U.S. Pharmacy Benefit Management End - use Market Share Analysis, 2022 & 2030
• 6.2 U.S. Pharmacy Benefit Management End - use Market: Segment Dashboard
• 6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the End - use Segment
  • 6.3.1 Commercial
    • 6.3.1.1 Commercial market, 2017 - 2030 (USD Billion)
  • 6.3.2 Federal
    • 6.3.2.1 Federal market, 2017 - 2030 (USD Billion)

Chapter 7 Competitive Analysis

• 7.1 Recent Developments & Impact Analysis, by Key Market Participants
• 7.2 Competition Categorization (Key innovators, Market leaders, Emerging Players
• 7.3 Company Market Position Analysis
• 7.4 Company Profiles
  • 7.4.1 CVS HEALTH
    • 7.4.1.1 Company overview
    • 7.4.1.2 Financial performance
    • 7.4.1.3 Service benchmarking
    • 7.4.1.4 Strategic initiatives
  • 7.4.2 Elixir Rx Solutions LLC
    • 7.4.2.1 Company overview
    • 7.4.2.2 Service benchmarking
    • 7.4.2.3 Strategic initiatives
  • 7.4.3 Optum, Inc
    • 7.4.3.1 Company overview
    • 7.4.3.2 Financial performance
    • 7.4.3.2 Service benchmarking
    • 7.4.3.3 Strategic initiatives
  • 7.4.4 Cigna
    • 7.4.4.1 Company overview
    • 7.4.4.2 Financial performance
    • 7.4.4.2 Service benchmarking
    • 7.4.4.3 Strategic initiatives
  • 7.4.5 Change Healthcare
    • 7.4.5.1 Company overview
    • 7.4.5.2 Service benchmarking
    • 7.4.5.3 Strategic initiatives
  • 7.4.6 MedImpact
    • 7.4.6.1 Company overview
    • 7.4.6.2 Financial performance
    • 7.4.6.3 Service benchmarking
    • 7.4.6.4 Strategic initiatives
  • 7.4.7 Prime Therapeutics LLC
    • 7.4.7.1 Company overview
    • 7.4.7.2 Service benchmarking
    • 7.4.7.3 Strategic initiatives
  • 7.4.8 HUB International Limited.
    • 7.4.8.1 Company overview
    • 7.4.8.2 Service benchmarking
    • 7.4.8.3 Strategic initiatives
  • 7.4.9 Anthem
    • 7.4.9.1 Company overview
    • 7.4.9.2 Financial performance
    • 7.4.9.3 Service benchmarking
    • 7.4.9.4 Strategic initiatives  

List of Tables

• TABLE 1 List of secondary sources
• TABLE 2 List of abbreviations
• TABLE 3 U.S. U.S. pharmacy benefit management market, by business model, 2017 - 2030 (USD Billion)
• TABLE 4 U.S. U.S. pharmacy benefit management market, by end-use, 2017 - 2030 (USD Billion)

List of Figures

• FIG. 1 Market research process
• FIG. 2 Information procurement
• FIG. 3 Primary research pattern
• FIG. 4 Market research approaches
• FIG. 5 Value chain based sizing & forecasting
• FIG. 6 QFD modeling for market share assessment
• FIG. 7 Market formulation & validation
• FIG. 8 Market outlook
• FIG. 9 Pharmacy benefit management market segmentation
• FIG. 10 Market trends & outlook
• FIG. 11 Market driver relevance analysis (Current & future impact)
• FIG. 12 Market restraint relevance analysis (Current & future impact)
• FIG. 13 Penetration & growth prospect mapping
• FIG. 14 U.S. pharmacy benefit management business model market share analysis, 2022 & 2030
• FIG. 15 U.S. pharmacy benefit management business model market: Segment dashboard
• FIG. 16 Standalone PBM market, 2017 - 2030 (USD Billion)
• FIG. 17 Health insurance providers market, 2017 - 2030 (USD Billion)
• FIG. 18 Retail pharmacy market, 2017- 2030 (USD Billion)
• FIG. 19 U.S. pharmacy benefit management market end-use movement analysis, 2022 & 2030
• FIG. 20 U.S. pharmacy benefit management end-use market: Segment dashboard
• FIG. 21 Commercial market, 2017 - 2030 (USD Billion)
• FIG. 22 Federal market, 2017- 2030 (USD Billion)
• FIG. 23 Recent developments & impact analysis, by key market participants
• FIG. 24 Strategy framework
• FIG. 25 Competition Categorization
• FIG. 26 Company market position analysis